Releases

22262 items in section

Beyond the Playground: How Rochester Field Trips Foster Social Skills

For children, an indoor play field trip in Rochester is far more than a simple break from the classroom. According to Play Palace CEO Kristen Bonn, these structured environments provide a critical laboratory for social-emotional growth, where navigating obstacle courses helps build resilience alongside physical coordination and motor development.

Wix Faces Investor Lawsuit Over AI Strategy and Cost Overruns

A 27% share price collapse in May 2026 has triggered a securities class action against Wix.com, with plaintiffs alleging the company misled shareholders about the financial burden and actual performance of its AI-driven initiatives, Base44 and Harmony, while failing to disclose the true extent of its mounting operational expenses.

Hagens Berman Launches Probe Into Photronics Over Plummeting Stock Value

A 36% single-day stock collapse has triggered a formal investigation into Photronics, Inc. by law firm Hagens Berman. The probe centers on allegations that the semiconductor supplier misled investors regarding the health of its high-end integrated circuit product pipeline during a volatile period between December 2025 and May 2026.

Hagens Berman Investigates Peabody Energy Over Centurion Mine Claims

The law firm Hagens Berman has launched an investigation into Peabody Energy following a class action lawsuit alleging the company misled investors about the production capabilities of its Centurion mine in Australia. The inquiry focuses on whether management concealed significant operational failures while maintaining positive financial guidance throughout 2025 and 2026.

Embecta Investors File Lawsuit Over Alleged Insulin Needle Misstatements

A 57.8% single-day stock plunge has triggered a federal securities class action against Embecta Corp. The lawsuit, filed in New Jersey, alleges the medical device company misled shareholders by painting a picture of stability for its insulin pen needle business while facing hidden competitive losses and retail volume declines.

Investors Face August Deadline in ADMA Biologics Securities Lawsuit

Investors who held ADMA Biologics stock between August 9, 2024, and March 25, 2026, face an August 10, 2026, deadline to seek lead plaintiff status in a newly filed class action lawsuit. The litigation targets alleged misrepresentations regarding company revenue, distribution practices, and undisclosed related-party transactions.

Erasca Faces Securities Lawsuit Over Oncology Candidate ERAS-0015

Investors who suffered losses in Erasca, Inc. stock between January 14, 2025, and April 26, 2026, face an August 10, 2026, deadline to seek lead plaintiff status. Hagens Berman is investigating allegations that the biotech firm misled shareholders regarding the competitive edge and safety of its lead cancer drug.

Michelle Onyiah Becomes First UPSHOT League Player to Sign WNBA Deal

Michelle Onyiah has secured a contract with the Indiana Fever, marking a historic breakthrough for the newly formed UPSHOT League. The 6-foot-3 forward, who dominated the frontcourt for the Charlotte Crown during the league's inaugural 2026 season, is the first athlete to transition directly to a WNBA roster.

Roblox Investors Face August 7 Deadline in Expanded Class Action Lawsuit

A securities class action against Roblox Corporation has entered a critical phase as law firm Hagens Berman expands the scope of its investigation. Investors who held common stock between October 31, 2024, and April 30, 2026, now have until August 7, 2026, to seek lead plaintiff status regarding the company’s safety disclosures.

Verra Mobility Investors Face August 4 Deadline in Securities Lawsuit

A 71 percent single-day stock crash has triggered a securities class action against Verra Mobility, as investors scramble to meet an August 4, 2026, deadline to seek lead plaintiff status. The litigation follows a sudden contract termination with Avis Budget Group that wiped out $1.4 billion in market value.

Hertz Faces Class Action Lawsuit After Stock Plunge

Investors who purchased Hertz Global Holdings stock between May 7 and June 23, 2026, face a September 22 deadline to join a securities fraud class action. The lawsuit follows a sharp decline in share price after the company revealed unexpected financial instability despite previous assurances of liquidity.

Investors Face August 4 Deadline in PicS Securities Lawsuit

Investors who purchased PicS N.V. stock during the company’s January 30 initial public offering have until August 4, 2026, to seek lead plaintiff status in a pending class action lawsuit. The litigation centers on claims that the firm concealed critical flaws in its credit underwriting processes prior to going public.

GRAIL Faces Securities Fraud Lawsuit Following NHS-Galleri Trial Failure

Investors who suffered significant losses in GRAIL, Inc. are facing an August 4, 2026, deadline to seek lead plaintiff status in a newly filed securities fraud class action. The lawsuit alleges that senior executives misled shareholders regarding the clinical efficacy and structural design of the company’s high-profile NHS-Galleri cancer screening trial.

Investors Face August Deadline in GeneDx Securities Fraud Lawsuit

Investors who suffered substantial losses from GeneDx Holdings Corp. stock now face an August 3, 2026, deadline to seek lead plaintiff status in a newly filed class action lawsuit. The litigation centers on claims that the company misled shareholders regarding the financial and operational integration of Fabric Genomics.

Electrolux Shareholders Convert Over 1.6 Million Class A Shares

A significant shift in the capital structure of AB Electrolux took place throughout July 2026, as shareholders exercised their right to convert 1,662,933 Class A shares into Class B shares. This strategic move resulted in a net reduction of the company’s total voting power by 1,496,639.7 votes.

American Regent Recalls Adequan Canine and Equine Injections

American Regent, Inc. Animal Health has issued a nationwide recall for specific lots of its Adequan Canine and Adequan i.m. joint medications. The voluntary action follows the discovery of glass fiber particulate matter within the injectable solutions during routine testing of internally retained samples.

Scaling Up: Managing Liability Risks for Commercial Contractors

A single dropped tool or a burst pipe can derail a high-stakes construction project, turning a profitable venture into a legal liability. Sissy LeClair-Blackadar, vice president of Blackadar Insurance Agency, outlines the essential coverage strategies contractors need to secure before bidding on larger commercial contracts.

Domain Market Trends Shift as .digital Surges in Q1 2026

Registration growth hit 40% year-over-year in the first quarter of 2026, yet the market landscape is undergoing a radical transformation. While the .com extension maintains its dominance, unexpected shifts in regional demand and the meteoric rise of specific top-level domains are forcing investors to rethink their portfolios.

Investors Sue PROCEPT BioRobotics Over Alleged Sales Inflation Scheme

A federal securities class action lawsuit accuses PROCEPT BioRobotics of artificially inflating revenue by pushing bulk handpiece discounts to customers, a practice that allegedly masked weak actual demand. The litigation targets claims made between February 2024 and February 2026, a period marked by repeated missed sales targets.

Primoris Services Hit by Class Action Over Renewables Project Failures

A federal securities class action lawsuit accuses Primoris Services Corporation of misleading investors about its project management capabilities, triggering a catastrophic $6 billion loss in market value. The litigation centers on persistent cost overruns and operational failures that remained hidden throughout the 2025-2026 fiscal year.

Regeneron Faces Class Action After Melanoma Drug Trial Failure

A $11 billion market cap wipeout has triggered a securities class action lawsuit against Regeneron Pharmaceuticals. Investors allege the company masked the failure of a Phase 3 trial for its melanoma therapy, Fianlimab, by repeatedly offering optimistic projections while internal data suggested the drug was failing to outperform standard treatments.

Black Rock Coffee Faces Class Action Over Alleged Expansion Missteps

Investors have leveled a securities class action against Black Rock Coffee Bar, alleging the company misled shareholders about the impact of its aggressive expansion strategy. The suit centers on claims that the coffee chain’s “concentric circle” growth model caused significant cannibalization of existing store revenue during its public offering.

Tianjin: Where the Haihe River Meets the Bohai Sea

Tianjin sits at the confluence of the Haihe River and the Bohai Sea, serving as a historic gateway between China and the international community. Once defined by 19th-century treaty port concessions, the city now balances its complex colonial legacy with a vibrant preservation of traditional Chinese crafts and coastal modernity.

Maryland businesses fuel growth through new investments and partnerships

From space-tech collaborations to major commercial real estate expansions, Maryland’s private sector is driving a wave of economic development across the state. State officials and industry leaders report that strategic investments are currently reshaping local healthcare, retail, and manufacturing landscapes through a series of high-profile projects.

Dallas-Based resbiotic Expands Microbiome Products to H-E-B Shelves

Returning to his professional roots, physician-scientist Dr. C. Vivek Lal has brought his Dallas-based company, resbiotic, to H-E-B stores across Texas. The expansion places the brand’s flagship Gut-Lung Axis probiotic and daily prebiotic powder into the hands of local consumers ahead of the state's challenging seasonal allergy cycles.

Hub Group Faces Class Action Over Accounting Irregularities

A federal securities class action has been initiated against Hub Group, Inc. following revelations that the logistics firm misstated financial results for three consecutive years. Investors allege that leadership concealed internal control failures and accounting errors that triggered a massive decline in the company’s market valuation throughout early 2026.

Texas Homeowners Warned of Post-Flood Contractor Scams

As floodwaters recede across Texas, the National Insurance Crime Bureau is tracking an influx of predatory contractors targeting vulnerable property owners. Officials warn that individuals exploiting the disaster often use high-pressure tactics, demanding upfront payments or encouraging homeowners to inflate damage claims to siphon off recovery funds.

Entergy Sets Quarterly Dividend at $0.64 Per Share

New Orleans-based Entergy Corporation will pay a quarterly dividend of $0.64 per share to common stockholders on September 1, 2026. The distribution follows a board of directors resolution, with the payout designated for shareholders registered on the company books by the close of business on August 13, 2026.

Nabsys and Indiana University Partner on Electronic Genome Mapping

Structural variation analysis in blood cancers remains a technical hurdle, prompting a new multi-year collaboration between Nabsys and the Indiana University School of Medicine. The partnership aims to integrate the OhmX platform into research workflows for acute myeloid leukemia and myelodysplastic syndromes to improve high-resolution genomic diagnostics.

Lexology Index Names Three Greenberg Traurig Partners to Competition List

Three attorneys from Greenberg Traurig’s global antitrust practice earned spots in the 2026 Lexology Index: Competition, a guide identifying top legal experts in regulatory and criminal matters. The recognition highlights the firm’s international reach as it manages complex merger filings and cartel investigations across multiple jurisdictions.